[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600389":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":19,"collaborators":11,"id":21,"slug":22,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":25,"acronym":11,"eligibilityCriteria":26,"healthyVolunteers":23,"sex":27,"minAge":28,"maxAge":11,"enrollmentInfo":29,"targetDuration":11,"studyType":32,"phases":33,"briefSummary":35,"conditions":36,"keywords":11,"overallStatus":38,"whyStopped":11,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":11},{"fullName":5,"class":6},"CMR Surgical Ltd","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Robotic-Assisted Cholecystectomy Using the Versius Surgical System","EXPERIMENTAL",null,[13],"Device: Robotic assisted cholecystectomy",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":11},"DEVICE","Robotic assisted cholecystectomy",[9],{"type":20,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100600389","post-market-clinical-study-to-evaluate-the-performance-of-the-versius-surgical-system-100600389",false,"NCT07096856","Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System","Inclusion Criteria:\n\n* 1\\. Adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy 2. Patients providing written informed consent to participate in the study\n\nExclusion Criteria:\n\n1. Patient unwilling to provide informed consent\n2. Patients undergoing surgery or treatment for malignant disease\n3. Patients undergoing a concomitant surgical procedure\n4. Medical contraindication for general anaesthesia or minimally invasive procedure\n5. Contraindication for undergoing surgery with Versius (Bleeding diathesis, Active pregnancy or BMI ≥40 kg\u002Fm2)","ALL","22 Years",{"count":30,"type":31},100,"ESTIMATED","INTERVENTIONAL",[34],"NA","The goal of this clinical trial is to learn how the Versius Surgical System, a robotic surgery device, works for gallbladder removal surgery (cholecystectomy) in adults. The main questions it aims to answer are:\n\nHow often can the surgery be successfully completed using Versius without needing to switch to a different surgical method?\n\nWhat serious complications, if any, occur within 30 days after surgery?\n\nResearchers will collect information from adult patients who have gallbladder surgery using the Versius system in U.S. hospitals. The purpose is to better understand how the device performs and how patients recover after surgery.\n\nParticipants will:\n\nBe adults age 22 or older who are eligible for minimally invasive gallbladder surgery\n\nUndergo robotic-assisted surgery using the Versius Surgical System\n\nAllow the research team to collect data during surgery and up to 30 days after\n\nComplete standard follow-up visits after discharge\n\nPatients with certain medical conditions, such as cancer, high BMI (≥40 kg\u002Fm²), or contraindications to anesthesia or robotic surgery, will not be included in the study.\n\nThis study is sponsored by CMR Surgical Ltd., the manufacturer of the Versius system.",[37],"Cholecystectomy, Robotic","NOT_YET_RECRUITING","2025-07-24",{"date":41,"type":42},"2025-07-31","ACTUAL",{"date":44,"type":31},"2025-12",{"date":46,"type":31},"2026-03",{"name":5,"class":6}]